Table III.
Clinical presentation symptoms in patients with SA in the United Kingdom and the United States
| Clinical site | Total no. of patients | Respiratory |
% | Urticaria |
% | Angioedema |
% | GI n | % | Eye/nasal |
% | Neurological n | % | Vascular shock |
% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | n | n | n | n | |||||||||||
| Preston | 43 | 23 | 53 | 13 | 30 | 29 | 67 | 19 | 44 | 3 | 7 | 2 | 5 | 6 | 14 |
| Sheffield | 122 | 50 | 41 | 50 | 41 | 58 | 48 | 36 | 30 | 17 | 14 | 3 | 2 | 1 | 1 |
| London | 20 | 6 | 30 | 6 | 30 | 10 | 50 | 5 | 25 | 1 | 5 | 3 | 15 | 2 | 10 |
| Cambridge | 66 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Houston | 48 | 9 | 19 | 17 | 35 | 19 | 40 | 1 | 2 | 6 | 13 | 0 | 0 | 0 | 0 |
| St Petersburg | 79 | 16 | 20 | NA | NA | 7 | 9 | 9 | 11 | NA | NA | 2 | 3 | ||
| Stanford | 567 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
NA, Not available/applicable.